Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “R-CHOP Chemotherapy”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01856192
What this trial is testing

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Diffuse Large B-Cell LymphomaAnn Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 349
Large-scale testing (Phase 3)Study completedNCT00536393
What this trial is testing

Treatment of Disseminated High Grade Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 100
Testing effectiveness (Phase 2)Study completedNCT02055820
What this trial is testing

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

Who this might be right for
Lymphoma, Non-Hodgkin
Hoffmann-La Roche 267
Not applicableStudy completedNCT00651755
What this trial is testing

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00355199
What this trial is testing

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

Who this might be right for
Diffuse Large B-Cell Lymphoma
Gruppo Italiano Terapie Innovative nei Linfomi 246
Testing effectiveness (Phase 2)Study completedNCT01448096
What this trial is testing

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse Lymphoma
Chonbuk National University Hospital 33
Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 68
Testing effectiveness (Phase 2)Study completedNCT00117897
What this trial is testing

Treatment for Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Testing effectiveness (Phase 2)Ended earlyNCT00906841
What this trial is testing

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
French Innovative Leukemia Organisation 75
Early research (Phase 1)Study completedNCT01334502
What this trial is testing

Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 26
Testing effectiveness (Phase 2)Looking for participantsNCT06569485
What this trial is testing

Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

Who this might be right for
DLBCL
Sun Yat-sen University 38
Not applicableStudy completedNCT01230008
What this trial is testing

Radiotherapy in Primary Mediastinal Lymphoma

Who this might be right for
Adjuvant Radiotherapy on Complete Remission Patients
Instituto Mexicano del Seguro Social 198
Early research (Phase 1)Study completedNCT03742258
What this trial is testing

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+4 more
Northwestern University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798156
What this trial is testing

Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 125
Large-scale testing (Phase 3)Study completedNCT01649856
What this trial is testing

Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)Study completedNCT02660710
What this trial is testing

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaHIV
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07588698
What this trial is testing

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)
Carrie Ho, MD 20
Testing effectiveness (Phase 2)Temporarily pausedNCT03704714
What this trial is testing

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaB-Cell Non-Hodgkin LymphomaCD20 Positive+5 more
Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT03465527
What this trial is testing

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Kosin University Gospel Hospital 37
Next Page